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Obesity is an increasingly serious health problem in the world. Body mass index (BMI), percentage fat mass, and
body fat mass are important indices of obesity. For a sample of pedigrees that contains 110,000 relative pairs
(including 1,249 sib pairs) that are useful for linkage analyses, we performed a whole-genome linkage scan, using
380 microsatellite markers to identify genomic regions that may contain quantitative-trait loci (QTLs) for obesity.
Each pedigree was ascertained through a proband who has extremely low bone mass, which translates into a low
BMI. A major QTL for BMI was identified on 2q14 near the marker D2S347 with a LOD score of 4.04 in two-
point analysis and a maximum LOD score (MLS) of 4.44 in multipoint analysis. The genomic region near 2q14
also achieved an MLS 12.0 for percentage of fat mass and body fat mass. For the putative QTL on 2q14, as much
as 28.2% of BMI variation (after adjustment for age and sex) may be attributable to this locus. In addition, several
other genomic regions that may contain obesity-related QTLs are suggested. For example, 1p36 near the marker
D1S468 may contain a QTL for BMI variation, with a LOD score of 2.75 in two-point analysis and an MLS of
2.09 in multipoint analysis. The genomic regions identified in this and earlier reports are compared for further
exploration in extension studies that use larger samples and/or denser markers for confirmation and fine-mapping
studies, to eventually identify major functional genes involved in obesity.
Introduction
Obesity is a disease condition with excess body fat that
adversely affects health (Kopelman 2000). Obesity is as-
sociated with many diseases, such as type 2 diabetes
mellitus, hypertension, coronary heart disease, and some
cancers (Must et al. 1999; Kopelman 2000). A higher
BMI (an important measure of obesity that expresses the
ratio of weight to the square of height in kilograms per
square meter) is associated with higher mortality (Calle
et al. 1999). About 250 million adults (7% of the world
adult population) are considered obese (defined as hav-
ing a BMI 130 kg/m2), and two or three times as many
may be considered overweight (defined as having a BMI
of 25–30 kg/m2) (Kuczmarski et al. 1994; Seidell 1999).
In the United States, 59.4% of men and 50.7% of
women are overweight or obese (Flegal et al. 1998). The
direct costs associated with obesity are estimated to be
∼$100 billion per year, which represents 5.7% of the
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national health expenditure in the United States in 1995
(Wolf and Colditz 1998). A more recent analysis shows
that the health care cost of obesity in the United States
is most likely between 0.89% and 4.32% (Allison et al.
1999b).
Obesity is a complex trait that is determined by mul-
tiple genetic and environmental factors (including phys-
iological, behavioral, and sociocultural factors) (Co-
muzzie and Allison 1998; Echwald 1999; Pe´russe and
Bouchard 1999). Numerous studies have been con-
ducted to characterize the heritability of obesity-related
phenotypes. Most studies are based on BMI, but a few
are based on fat mass and percentage fat mass (PFM)
and a few on lean mass. The estimates of heritability
(h2) of BMI ranged from 0.05 to 0.90 (Stunkard et al.
1986, 1990; Bouchard et al. 1988; Selby et al. 1991;
Harris et al. 1995; Vogler et al. 1995; Allison et al.
1996; Borecki et al. 1998; Rice et al. 1999). For fat
mass, h2 estimates range from 20% to 65% (Bouchard
et al. 1988; Comuzzie et al. 1995, 1997; Rice et al.
1997a; Samaras et al. 1997; Nguyen et al. 1998). For
PFM, h2 estimates are 62%–80% (Rice et al. 1997b;
Sakurai et al. 1997; Faith et al. 1999). In h2 studies of
fat mass and PFM, few have employed measurement by
dual energy x-ray absorptiometry (DXA) (but see Sam-
aras et al. 1997 andNguyen et al. 1998), largely because
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of the relatively recent availability of DXA and its as-
sociated relatively large expenses for the measurement.
For lean mass, h2 estimates are 0.52%–0.80% (Forbes
et al. 1995; Arden and Spector 1997; Nguyen et al.
1998). In our study sample, after adjustment for age,
sex, and life style factors, h2, estimates of BMI, fat mass,
PFM, and lean mass (the latter three phenotypes mea-
sured by DXA) are 0.52%–0.57% (Deng et al. 2001a).
The number and the identity of the genes underlying
the susceptibility to obesity have received extensive study
(Comuzzie and Allison 1998; Echwald 1999; Pe´russe and
Bouchard 1999). For the common variation of obesity
phenotypes, segregation analyses in several populations
suggest that major genes with recessive effects may ac-
count for 35%–45% of the variation in obesity-related
phenotypes (e.g., BMI, fat mass, and PFM), after ad-
justment for sex and age (Moll et al. 1991; Rice et al.
1993; Comuzzie et al. 1995). Other segregation analyses
did not reveal any major gene effect but inferred the
existence of multiple genes, each with minor effects (Le-
comte et al. 1997; Borecki et al. 1998). A number of
candidate genes have been tested by association and/or
linkage for obesity phenotypes (Deng et al. 2000b; Pe´-
russe et al 2001). Genomewide linkage studies have been
conducted, and several genomic regions have been re-
ported that may harbor obesity-susceptibility genes (Co-
muzzie et al. 1997; Hager et al. 1998; Hanson et al. 1998;
Norman et al. 1998; Lee et al. 1999; Mitchell et al. 1999;
Walder et al. 2000; Watanabe et al. 2000; Hsueh et al.
2001; Feitosa et al. 2002). The genomic regions identified
so far seem to be largely unconfirmed (Pe´russe et al.
2001), except in a few cases (e.g., a QTL for serum leptin
concentration on 2p21 [Comuzzie et al. 1997; Hager et
al. 1998] and a locus for obesity on 10p [Hager et al.
1998; Hinney et al. 2000]). Hence, further gene-mapping
studies in various samples and populations are war-
ranted. Only by comparing different studies of various
population samples and by disentangling biological and
statistical causes that underlie the consistent results—as
well as the inconsistent ones—maywe eventually identify
major QTLs for obesity.
In the present study, we genotyped 380 highly het-
erozygous markers across the whole genome for each
of the 630 subjects, who are members of 53 white ped-
igrees that contain 110,000 relative pairs (including
1,249 sib pairs) that are useful for linkage analyses. We
performed a whole-genome linkage scan to identify ge-
nomic regions that are potentially important for obesity
phenotypes. The study identified a major QTL for BMI
and several other genomic regions of potential impor-
tance for BMI, fat mass, PFM, and lean mass, and it
provides a basis for further extension and confirmation
studies for these putative genomic regions and for close
examination of the candidate genes identified inside
these genomic regions in the present study population.
Subjects and Methods
Subjects
The study was approved by the Creighton University
institutional review board. All the study subjects signed
informed-consent documents before entering the project.
The study subjects came from an expanding database
that is being created for studies to search for genes un-
derlying the risk of osteoporosis and obesity that is un-
derway in the Osteoporosis Research Center of Creigh-
ton University. Only healthy people (defined by the
exclusion criteria that are detailed below) were included
in the analysis. All the study subjects were white indi-
viduals of European origin, and 53 pedigrees with 630
subjects (248 males and 382 females) from 2–4 gener-
ations were analyzed. The pedigrees range from 3 to 99
individuals, with a mean (SE) of 11.7 (2.4). Each ped-
igree was identified through a proband having bonemin-
eral density (BMD) Z scores less than 1.28 at the hip
or spine. BMD values expressed as Z scores adjust for
age, sex, and ethnic difference in healthy referent pop-
ulations. Hence, to identify QTLs for BMD (Deng et al.
2001b), we selected the probands from the lowest 10%
of the population BMD variation for the purpose of
achieving higher statistical power than would be
achieved through random sampling (Risch and Zhang
1995; Deng and Li, in press). Because BMD and BMI
are significantly correlated (Deng et al. 2000a), the sam-
pling scheme of our study pedigrees for enhancing the
power of linkage analysis to detect genomic regions for
BMD variation may also have a similar effect (if any)
on BMI and related obesity phenotypes. In fact, the pro-
bands tend to have BMI that are lower than the average
in their pedigrees (see “Results” section).
The exclusion criteria for the study subjects were a
history of (1) serious residual effects of cerebral vascular
disease; (2) diabetes mellitus, except for easily con-
trolled, non–insulin-dependent diabetesmellitus (defined
as adult asymptomatic hyperglycemia controlled by diet
or oral agents); (3) chronic renal disease manifested by
serum creatinine 11.9 mg/dl; (4) chronic liver disease or
alcoholism; (5) significant chronic lung disease; (6) 16
mo of corticosteroid therapy at pharmacologic levels;
(7) 16 mo of treatment with anticonvulsant therapy; (8)
evidence of other metabolic or inherited bone disease,
such as hyper- or hypoparathyroidism, Paget disease,
osteomalacia, or osteogenesis imperfecta; (9) rheuma-
toid arthritis or collagen disease; (10) recent (within the
past year) major gastrointestinal disease, such as peptic
ulcer, malabsorption, chronic ulcerative colitis, regional
enteritis, or any significant chronic diarrhea state; (11)
significant disease of any endocrine organ that would
affect bone mass; (12) hyperthyroidism; (13) any neu-
rologic or musculoskeletal condition that would be a
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nongenetic cause of low bonemass; and (14) any disease,
treatment, or condition that would be a nongenetic cause
of low bone mass. The exclusion criteria were assessed
by nurse-administered questionnaires and/or examina-
tion of medical records and were appliedmost rigorously
to potential subjects contacted between the ages of 25
and 50 years. About 5.1% of the total people screened
were excluded from our study sample because they met
at least one of the exclusion criteria. The exclusion cri-
teria applied might render the allele frequencies and thus
the genetic effects of potential obesity QTLs different
from those in our general population. This may be the
case when some of the above disease states are geneti-
cally correlated with obesity, for which there is generally
no evidence at present.
Genotyping
For each subject, blood (20 cc) was drawn into EDTA-
containing tubes by certified phlebotomists and was
stored chilled (∼4C) until DNA extraction, which was
usually completed within the next five calendar days.
DNA was extracted by employing a kit (Gentra Systems),
according to the procedures detailed in themanufacturer’s
instructions. DNA was genotyped using fluorescently la-
beled markers, as we did before (Deng et al. 2000c). The
400 dinucleotide markers with which we started our ge-
notyping are commercially available through Perkin-El-
mer Applied Biosystems (ABI Prism Linkage Mapping
Sets, version 2). The PCR was performed on PE 9700
thermocyclers (Applied Biosystems). PCR cycling condi-
tions followed those suggested in the ABI Prism Linkage
Mapping Sets, version 2. Genotyping was performed us-
ing Applied Biosystems automated DNA sequencing sys-
tems (models 377 and 310) running the Genescan and
Genotyper softwares for allele identification and sizing.
A genetic database management system (GenoDB) de-
veloped by us (Li et al. 2001) was employed to manage
the phenotype and genotype data for linkage analyses.
GenoDB is also employed for allele binning (including
setting up allele-binning criteria and converting allele sizes
to distinct allele numbers), quality control, and formatting
of data for PedCheck (O’Connell and Weeks 1998) and
for linkage analyses by SOLAR. PedCheck was employed
for checking the conformation to Mendelian inheritance
patterns at all the marker loci and for checking the re-
lationships of family members within pedigrees. The ge-
notyping error rate, determined by at least three rounds
of sample replication in experiments and data analyses
by PedCheck, was ∼0.3%.Of the markers, 380 (including
362 on autosomes) were successfully genotyped. These
markers have an average population heterozygosity of
∼0.79 and are spaced an average of ∼8.6 cM from ad-
jacent markers throughout the human genome.
Measurement
Fat mass and lean mass were measured by DXA with
a Hologic 2000 or 4500 scanner. Measurements of
BMD on the two types of machines agreed within 1%,
but the body mass measurements differed in an unsys-
tematic way. For 24 people who underwent scans on the
same day on the two types of machines, the difference in
whole body mass is ∼3%. All machines were calibrated
daily. The body-composition bar was used on every
whole-body scan on the Hologic 2000. On the Hologic
4500, the bar was not needed for the body scans; instead,
it was scanned every week. In the early stage of the study,
the subjects were recruited for studying osteoporosis only.
Thus, we did not install the hardware and software to
perform the body composition assessment until later in
the recruitment for the project. Therefore, we have data
on fat mass, PFM, and lean mass for only 289 subjects
from 38 pedigrees. Software and hardware have been kept
up to date throughout the implementation of the project.
For the Hologic 2000 scanner that was in service during
1994–1999, the software was updated from version5.67a
to version 5.71a. For the Hologic 4500 scanner that has
been in service since 1997, the software has been updated
from version 8.19a to version 8.26a. The PFM is the ratio
of fat mass divided by body weight (i.e., the sum of fat
mass plus lean mass plus bone mineral content). Themea-
surement precision of BMI as reflected by coefficient of
variation was 0.2%. The coefficients of variation for fat
mass, PFM, and lean mass were 2.2%, 2.2%, and 1.0%,
respectively, for measurements obtained on the Hologic
2000, and were 1.2%, 1.1%, and 0.7%, respectively,
for measurements obtained on the Hologic 4500. Mem-
bers of the same pedigree were usually measured on the
same type of machine.
Statistical Analyses
A variance-component linkage analysis (Amos 1994;
Amos et al. 1996; Almasy and Blangero 1998) for quan-
titative traits was performed. The analysis is based on
specifying the expected genetic covariances between rel-
atives as a function of the identity by descent at a given
marker locus. The analysis considers the phenotypic and
genetic information from all pedigree members simulta-
neously. The analysis assumed joint multivariate nor-
mality of phenotypic values, additive genetic effects, and
no interaction between genes and the residual. The pro-
gram employed was SOLAR (Sequential Oligogenic Link-
age Analysis Routines) (Almasy and Blangero 1998),
which is available on the Internet. The pedigree-ascer-
tainment scheme based on the low BMD values of pro-
bands leads to lower-than-average BMI values (see “Re-
sults”). The ascertainment scheme was accounted for in
the analyses by identifying to the program the probands
and their phenotypic values for each pedigree. The built-
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in modules of the SOLAR program will then be able to
account for the ascertainment scheme by using condi-
tional likelihoods in LOD score computation. The statis-
tical properties of the variance-component analyses after
the ascertainment correction have been preliminarily in-
vestigated (de Andrade et al. 1997; de Andrade and Amos
2000; Sham 2000).
In linkage analysis, age and sex were adjusted as co-
variates for the obesity phenotypic values, because these
generally affect the variation of obesity phenotypes sig-
nificantly in our study population (Deng et al. 2000b).
Analyses were also performed without adjusting for one
or both of these covariates. Adjustment for significant
covariates in genetic analyses can generally increase the
genetic signal-to-noise ratio in linkage detection by de-
creasing the proportion of the residual phenotypic var-
iation attributable to random environmental factors
(Deng et al. 1999). This may thus improve statistical
power in our linkage analyses. Comparison of the anal-
yses with and without adjustment for a significant co-
variate may shed light on the genomic regions identified
regarding their direct importance for the trait per se or
indirect importance via the influence on the covariate
only. The variance-component analyses implemented in
SOLAR are generally robust to violations of normality
of the data (Williams et al. 1999). However, some types
of nonnormality of the data may inflate the type I error
rate in excess of specified nominal levels (Allison et al.
1999a). The phenotype data were tested by graphical
methods (Sokal and Rohlf 1995) and found not to de-
viate from normal distributions. Marker-allele frequen-
cies were obtained by maximum likelihood estimation
in SOLAR. Hypothesis testing for linkagewas conducted
by the maximum-likelihood method by investigating the
relationship of genetic covariances and the identity-by-
descent between relatives. The method compares the
maximum likelihoods obtained in the full model (which
shows linkage so the locus is a QTL and accounts for
some additive genetic variance) with the nested null
model (which does not show linkage so the locus is not
a QTL). The difference between the two log10 likelihoods
yields a LOD score. Twice the difference of the loge of
the likelihoods of these two models is asymptotically
distributed as a : mixture of a x2 variable and a point1 12 2
mass at 0 (Almasy and Blangero 1998) with 1 df. Using
SOLAR, we performed two-point and multipoint link-
age analyses, respectively, for the obesity phenotypes.
LOD scores may be converted to approximate P values
(prior to accounting for multiple testing), which is com-
monly employed in statistical testing through a x2 dis-
tribution (Lander and Kruglyak 1995). When a putative
QTL is suggested, the proportion of phenotypic varia-
tion attributable to this QTL can be estimated by SO-
LAR. The estimate is usually an upper bound of the
genetic effect due to the locus (Go¨ring et al 2001).
Results
The basic characteristics of the study subjects, stratified
by age and sex, are summarized in Appendix A (table
3). Some information about the family structure of the
study pedigrees is summarized in Appendix B (table 4).
Appendix B shows that, for the analyses for BMI, there
are 110,000 informative relative pairs (including 1,249
sibling pairs, 1,098 grandparent-grandchild pairs, 1,993
avuncular pairs, and 2,589 first-cousin pairs). For the
analyses for fat mass, lean mass and PFM, there are
nearly 6,000 informative relative pairs (including 744
sibling pairs, 710 grandparent-grandchild pairs, 1,148
avuncular pairs, and 1,500 first-cousin pairs). These
large numbers of informative relative pairs reflect the
richness of the genetic information for linkage analyses
in our sample. The correlations between BMI and spine
and hip BMD are, respectively, 0.27 and 0.44, both sig-
nificant at . In our sample, the mean (SE) of BMI,P ! .01
adjusted for age and sex, is 26.45 (0.21) for all the sub-
jects and is 23.97 (0.63) for probands. The BMI value
is significantly smaller ( ) in the probands, reflect-P ! .01
ing our sampling scheme through low BMD values.
The results for the chromosomes that had amaximum
LOD score 12.0 in multipoint linkage analyses for any
one of the four obesity phenotypes are summarized in
figure 1, the results for the other chromosomes are sum-
marized in figure 2. Because the current version of SO-
LAR does not handle multipoint linkage analyses for
the X chromosome, to convey the linkage signal pattern
on the X chromosome, we plotted two-point LOD score
results for the X chromosome (fig. 2). For the analysis
results presented, obesity phenotypes were adjusted, by
use of multiple regression, for significant covariates of
age and sex. The results (not shown) of the linkage
analyses for obesity phenotypes that were not adjusted
for covariates showed a similar pattern in LOD scores
and qualitatively the same results, suggesting that any
impact of the genomic regions identified here produces
a direct effect on obesity phenotypes rather than influ-
encing phenotypes through a covariate.
Notably (fig. 1 and tables 1 and 2), for BMI, a major
QTL on 2q14 is identified with a maximum LOD score
(MLS) of 4.44 ( ) at 128 cM from pter onPp .000003
chromosome 2 in multipoint linkage analyses. In two-
point linkage analyses, a LOD score of 4.04 (Pp
) is achieved at the marker D2S347 on 2q14..000008
For this putative major QTL for BMI, asmuch as 28.2%
of BMI variation (after adjustment for age and sex) may
be attributable to this locus. In addition, the importance
of this genomic region is manifested for PFM and body
fat mass. For PFM, 2q14 may contain a QTL with an
MLS of 2.10 ( ) at 128 cM from pter onPp .00093
chromosome 2 in multipoint analyses, and a LOD score
of 1.91 ( ) is achieved at the marker D2S347Pp .0015
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Figure 1 Multipoint linkage analysis results for the chromosomes that had an MLS 12.0. Results are shown for BMI (black), PFM (green),
fat mass (red), and lean mass (blue).
on 2q14 in two-point analyses. For body fat mass, 2q14
achieved an MLS of 2.21 ( ) at 128 cM fromPp .0007
pter on chromosome 2 in multipoint analyses, and in
two-point analyses, a LOD score of 2.03 ( )Pp .0011
is achieved at D2S347 on 2q14.
In addition to the genomic region 2q14, a few other
genomic regions were identified that had LOD scores
11.5 and that may harbor QTLs for the obesity phe-
notypes under study (fig. 1 and table 1). For BMI, four
additional genomic regions were suggested. Region
1p36 may contain a QTL with an MLS of 2.09 (Pp
) at the terminal end of short arm on chromo-.00095
some 1 in multipoint analyses. In two-point analyses, a
LOD score of 2.75 ( ) is achieved at D1S468Pp .00019
on 1p36. Region 4q12 may contain a QTLwith anMLS
of 2.09 ( ) at 68 cM from pter on chro-Pp .00096
mosome 4 in multipoint analyses. In two-point analyses,
a LOD score of 2.29 ( ) is achieved atPp .00058
D4S1592 on 4q12. Two genomic regions with LOD
scores 11.50 in either multi- or two-point linkage anal-
yses (fig. 2; table 1) are also noticeable. The genetic
signals manifested in these genomic regions may deserve
further close examination in extended samples and/or
denser molecular markers. These noteworthy genomic
regions include 6q27 with an MLS of 1.61 (Pp
) in multipoint analyses at 188 cM from pter on.0032
chromosome 6 in multipoint analyses, and those at the
marker D6S281 on 6q27 with a LOD score of 1.77
( ), the marker D2S160 on 2q12 with a LODPp .0021
score of 2.56 ( ), in two-point analyses. ForPp .00030
PFM, in two-point analyses, a LOD score of 1.95
( ) is achieved at D2S206 on 2q36; 8q24Pp .0014
achieved an MLS of 1.54 ( ) in multipointPp .0039
analyses.
For fat mass, 6q27 achieved an MLS of 1.59 (Pp
) at 188 cM from pter on chromosome 6 in mul-.0034
tipoint analyses. In two-point analyses, a LOD score of
2.02 ( ) is achieved at D6S281 on 6q27. ThePp .0011
other noteworthy genomic regions are 20q13, which
achieved an MLS of 1.64 ( ) at 69 cM fromPp .0030
the pter in multipoint analyses, and the marker D8S549
on 8p22, which achieved a LOD score of 1.95 (Pp
) in two-point analyses..0014
For lean mass, we did not detect any genomic region
showing a LOD score 12.0 in multipoint or two-point
linkage analyses. Some genomic regions with LOD
scores 11.50 are noteworthy. In multipoint analyses,
these genomic regions include 12q14 with an MLS of
1.64 ( ) at 82 cM from pter on chromosomePp .0030
12, 17p12 with an MLS of 1.63 ( ) at 33 cMPp .0031
from the pter on chromosome 17, and 7p22 with an
MLS of 1.52 ( ) at 5 cM from pter on chro-Pp .0041
mosome 7. In two-point analyses, a LOD score of 1.79
( ) is achieved at D12S83 on 12q14, and aPp .0020
LOD score of 1.59 is achieved at D5S407 on 5q11.
Because the pedigree size varies dramatically (from 3
to 99), we performed additional linkage analyses for the
largest pedigree and for the rest of the pedigrees. We
found that the evidence from the two independent sub-
samples generally provide support for each other for the
major significant results presented for the combined sam-
ple, although the significance is weaker in the subsamples.
Discussion
Various phenotypes have been employed for obesity re-
search. The World Health Organization proposed BMI
as a simple measure of obesity. BMI has been used
widely, because it can be measured conveniently at low
cost for large samples (Comuzzie and Allison 1998).
Figure 2 Multipoint linkage analysis results for the autosomes that had a maximum LOD score !2.0 and the two-point linkage analysis results for the X chromosome. Results are shown for
BMI (black), PFM (green), fat mass (red), and lean mass (blue). Note that the scale of the Y-axis is different from that in figure 1.
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Table 1
Markers and Genomic Regions with LOD Scores 11.5 in Two-Point Linkage Analyses for Obesity Phenotype Variation and the Identified
Candidate Genes inside the Genomic Regions
Phenotypes
and Marker
Chromosome
Location
LOD
Score QTLs in Animal Models
BMI:a
D1S468 1p36 (4.2 cM from pter) 2.75 10%–13% Abdominal fat (Brockmann et al. 1998) and 16% BMI (Kovacs et al. 1997)
D2S347 2q14 (131.5 cM from pter) 4.04 Adiposity (Pomp 1997)
D2S160 2q12 (123.0 cM from pter) 2.56 1.9% Late weight gain (Cheverud et al. 1996; Vaughn et al. 1999)
D4S1592 4q12 (69.5 cM from pter) 2.29 4% 6-wk Weight gain (Keightley et al. 1996)
D6S281 6q27 (190.1 cM from pter) 1.77 6.1% Adiposity (Taylor et al. 1997)
PFM:
D2S206 2q36 (240.8 cM from pter) 1.95 Subcutaneous fat (Mehrabian et al. 1998); 10.9% body weight (Hirayama et al. 1999)
D2S347 2q14 (131.5 cM from pter) 1.91 Adiposity (Pomp 1997)
Fat Mass:
D2S347 2q14 (131.5 cM from pter) 2.03 Adiposity (Pomp 1997)
D6S281 6q27 (190.1 cM from pter) 2.02 6.1% Adiposity (Taylor et al. 1997)
D8S549 8p22 (31.7 cM from pter) 1.95 24% Body weight (Gauguier et al. 1996)
Lean Mass:
D12S83 12q14 (75.2 cM from pter) 1.79
D5S407 5q11 (64.7 cM from pter) 1.59 Adiposity (Pomp 1997)
a Candidate genes for BMI are as follows: PGD is involved in carbohydrate metabolism. Enzyme catalyzes a step in the pentose pathway
and oxidizes glucose-6-phosphate into 6-phosphoglucono-lactone (Wilson et al. 1991). TNFR2 is a polymorphism of the TNFR2 gene, which
is associated with obesity, leptin levels, and insulin resistance. (Fernandez-Real et al. 2000). NR0B2 mutations are related to early-onset mild
obesity (Nishigori et al. 2001). The candidate genes and their cellular functions (if indicated) in the genomic regions are identified via the human
obesity gene map (Pe´russe et al. 2001) or Online Mendelian Inheritance in Man. The genetic distances are as indicated by the Marshfield linkage
map.
However, BMI cannot distinguish fat mass from lean
mass and thus may not always be appropriate (Allison
and Saunders 2000). For example, athletes often have a
BMI 125 kg/m2, along with only 10%–15% body fat
(Allison and Saunders 2000). Body fat mass and PFM
are considered phenotypically more homogeneous than
BMI and are more appropriate as phenotypes for obesity
research (Lecomte et al. 1997). However, because fat
mass and PFM cannot be measured easily and inexpen-
sively, they have not been used as widely as BMI. It may
also be important to study body lean mass, because ex-
cess body weight consists of not only fat mass but also
lean mass (Chagnon et al. 2000).
Our purpose is to identify, through a whole-genome
scan and by comparison with earlier studies, genomic
regions that may contain QTLs underlying the variation
of obesity phenotypes. For a sample of pedigrees that
contains 110,000 useful relative pairs, we performed a
whole-genome linkage scan, using 380 microsatellite
markers (with an average heterozygosity of ∼0.79 and
spaced ∼8.6 cM apart throughout the whole human ge-
nome). For whole-genome linkage studies, phenotypic
characteristics and measurement quality of pheno-
types—as reflected by coefficient of variation—are often
summarized. However, the quality of genotyping data,
an important aspect of whole-genome linkage studies and
genetic studies involving genotyping in general (Gordon
et al. 2001), has seldom been reported. The genotyping
quality should also be reported, because it affects the
assessment of the quality of data and thus the robustness
of results in linkage studies (Terwilliger et al. 1990). The
rate of absent or erroneous genotyping data is estimated
to be quite low (0.3%) in our study, a fact that is expected
to contribute to the strength of our linkage results.
Our sample was recruited for the purpose of effi-
ciently locating genes that underlie BMD (Deng et al.
2001b), and BMD and body weight are known to be
correlated (Deng et al. 2000a). Because bone mass is a
part of body mass, BMD and BMI may also share some
genes underlying their variation, although the signifi-
cance of the shared genetic determination is unknown
and is not revealed by comparison of our results in the
present study with those from another of our other stud-
ies (H.W.D., G.H.X., Q.Y.H., H.S., H.Y.D., Y.J.L., T.C.,
J.I.L., H.T.Z., K.M.D., and R.R.R., unpublished data).
The ascertainment of our multigeneration pedigrees
through probands with extremely low BMD values
translates into lower-than-average BMI values of the
probands, a practice that may yield improved power if
any effect is present (Risch and Zhang 1995; Deng and
Li, in press) in our sample. The strategy for identifying
genes for obesity is, essentially, to search for genes un-
derlying the variation of obesity phenotypes. The re-
cruitment of pedigrees via probands with low BMI and
the use of genetic studies of thinness may yield impor-
tant and complementary findings to genetic studies of
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Table 2
Markers and Genomic Regions with LOD Scores 11.5 in Multipoint Linkage Analyses for Obesity Phenotype Variation and
the Identified Candidate Genes inside the Genomic Regions
Phenotype and
Chromosome Location
LOD
Score QTLs in Animal Models
BMI:a
1p36 (0 cM from pter) 2.09 See table 1
2q14 (128 cM from pter) 4.44 See table 1
4q12 (68 cM from pter) 2.09 See table 1
6q27 (188 cM from pter) 1.61 See table 1
PFM:
2q14 (128 cM from pter) 2.10 1.9% Late weight gain (Cheverud et al. 1996; Vaughn et al. 1999)
8q24 (149 cM from pter) 1.54 14.4% 14-wk % Fat (Horvat et al. 2000); 24% body weight (Gauguier et al. 1996)
Fat mass:b
2q14 (128 cM from pter) 2.21 1.9% Late weight gain (Cheverud et al. 1996); Vaughn et al. 1999)
6q27 (188 cM from pter) 1.59 See table 1
20q13 (69 cM from pter) 1.64
Lean mass:
12q14 (82 cM from pter) 1.64
17p12 (33 cM from pter) 1.64
7p22 (5 cM from pter) 1.52 4.9% 14-wk % Fat (Horvat et al. 2000); 5.4% weight (Chung et al. 1997)
a PGD, TNFR2, and NR0B2 are candidate genes for BMI. See table 1, footnote a.
b See “Discussion” section.
obesity conducted by ascertainment through obese sub-
jects (Bulik and Allison 2001). The loci identified via
the ascertainment of low or high extreme phenotype
distribution should all be those important for the var-
iation of obesity phenotypes and thus are important for
obesity research. The efficacy of gene identification via
ascertainment through probands of extremely low or
extremely high phenotypic values has been demonstrated
(e.g., Risch and Zhang 1995; Deng and Li, in press). In
our study, the larger sample size for the analyses of BMI
yields higher statistical power than that for fat mass, lean
mass and PFM. The total sample in our study is in the
intermediate range compared with earlier genomewide
scan studies for obesity (Comuzzie et al. 1997; Hager et
al. 1998; Hanson et al. 1998; Norman et al. 1998; Lee
et al. 1999; Mitchell et al. 1999; Walder et al. 2000;
Watanabe et al. 2000; Hsueh et al. 2001; Feitosa et al.
2002). The exact power of each study may depend not
only on the total sample size but also on a number of
other factors, such as pedigree structure, study design
and analyses, genotyping quality andmolecularmarkers
employed, specific phenotypes under study, potential
population-specific genetic effects of QTLs, phenotype
distribution within pedigrees or relative pairs, and as-
certainment scheme. It would be interesting, in the fu-
ture, to compare the linkage results obtained in refer-
ence to the relative power under various conditions for
various studies involving linkage scans.
Several genomic regions that may contain QTLs for
the variation of the obesity phenotypes studied were
identified. Notably, the genomic region near the marker
D2S347 on chromosome 2 may contain a QTL for BMI
variation. We estimate that this QTL may explain as
much as 28.2% of BMI variation (after adjustment for
age and sex). In addition, there are several genomic
regions identified for the obesity phenotypes studied
with LOD scores 11.5 in two- and/or multipoint linkage
analyses. Several of the genomic regions identified/sug-
gested coincide with earlier QTL-mapping studies from
animal models and harbor several candidate genes (table
1). The importance of chromosome 2 has been revealed
for serum leptin concentration and/or fat mass (Co-
muzzie et al. 1997; Hager et al. 1998). The exact po-
sitions of the peak LOD scores (and thus the QTLs
involved) reported by Comuzzie et al. (1997), Hager et
al. (1998), and ourselves are different on chromosome
2 (∼80 cM apart on the Marshfield linkage map). How-
ever, the importance of chromosome 2 in obesity eti-
ology seems to be corroborated by a putative QTL re-
gion we identified on this chromosome. Several mouse
studies have suggested that genes influencing body
weight and fatness may be located on chromosome 2,
in regions homologous to human chromosome 2q
(Pomp 1997), which further strengthens the importance
of chromosome 2 for obesity. The peak on chromosome
1 (1p36) coincided with the region containing the gene
TNFR2 (tumor necrosis factor-a receptor 2), whose
polymorphism is associated with obesity, leptin levels,
and insulin resistance (Fernandez-Real et al. 2000). In
addition, mutations of NR0B2 (nuclear receptor sub-
family 0, group B, member 2) were reported to be as-
sociated with early-onset mild obesity (Nishigori et al.
2001). Several of the other genomic regions identified/
suggested, such as 4q12 and 6q27, coincide with earlier
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QTL-mapping studies from animal models and several
candidate genes are suggested (Keightley et al. 1996;
Taylor et al. 1997).
On chromosome 20q13, Lee et al. (1999) demon-
strated a QTL for BMI and PFM; the LOD scores of
BMI, PFM, and fat mass in our pedigrees are, respec-
tively, 0.52 ( ), 0.85 ( ) and 1.64Pp .061 Pp .024
( ) on 20q13. Considering that the strength ofPp .003
evidence required for replication of a previously found
linkage is different from that in a whole-genome linkage
analysis (Lander and Kruglyak 1995), our results lend
support to the finding by Lee et al. (1999) that chro-
mosome 20 may harbor a QTL affecting obesity phe-
notypes. The chromosome region 20q11-13 contains
several putative candidate genes for obesity, as outlined
below. Agouti-signaling protein (ASIP), whose gene is
located on 20q11-13, is a potent inhibitor of a-mela-
nocyte-stimulating hormone receptors 3 and 4 (MC3R
and MC4R) (Fong et al. 1997), and the lack of func-
tional MC4R leads to obesity in mice (Huszar et al.
1997). Mutations of agouti gene on 20q11-13 lead to
obesity in mice (Miller et al. 1993). CEBPB (CAAT/
enhancer-binding protein b) is related to adipocyte dif-
ferentiation and is considered one of the candidate genes
(Yeh et al. 1995). Mutations of GNAS1 (guanine nu-
cleotide-binding protein, alpha stimulating activity
polypeptide 1) in 20q11-13 is associated with Albright
hereditary oteodystrophy, which is partly characterized
by obesity (Gunay-Aygen et al. 1997).
Our data show that, except for the body lean mass
and fat mass, the traits analyzed are generally correlated
significantly. The phenotypic correlations are, respec-
tively, 0.83 (between BMI and fat mass), 0.33 (between
BMI and lean mass), 0.51 (between BMI and PFM),
0.03 (between fat mass and lean mass), 0.84 (between
body fat mass and PFM), and 0.48 (between body
lean mass and PFM). However, a significant and high
phenotypic correlation does not necessarily imply a sig-
nificant and high genetic correlation (Deng et al. 2002),
which indexes the degree of shared genetic determina-
tion of two phenotypes. Hence, it is not surprising that,
although some loci identified in this study show linkage
signal to multiple phenotypes (e.g., 2q14 for BMI, PFM,
and body fat mass), other loci identified are somewhat
more phenotype specific. The polygenic nature of inher-
itance (Deng et al. 2001b) and the different sample sizes
for the analyses of BMI and other phenotypes may con-
tribute to some of the different findings for various phe-
notypes. When multiple correlated phenotypes are em-
ployed in analyses, LOD scores need to be judged in
consideration ofmultiple testing.We performed our anal-
yses for individual phenotypes in this study; alternatively,
multivariate analyses may be performed (Allison et al.
1998). In another report (Deng et al., in press), we used
factor scores of the principal component of various bone
mass phenotypes in complex segregation analyses. How-
ever, when the same strategy of multivariate analyses is
employed in our linkage analyses for bone sizes at dif-
ferent skeletal sites, multivariate analysis is less sensitive
individual univariate analyses in detecting linkage signals
(Q.Y.H., F.H.X., H.S., H.Y.D., T.C., Y.J.L., Y.Z.L., J.L.L.,
K.M.D., R.R.R., and H.W.D., unpublished data). This
may be due to heterogeneity in genetic determination of
individual loci to different phenotypes involved, a topic
that we wish to pursue elsewhere.
The genomic regions identified in this and earlier
studies need to be subject to extension studies withmore
samples and denser markers for confirmation. Those
genomic regions and chromosomes that are cross-
supported by several types of study (e.g., linkage analyses
in humans, QTL mapping in animal models, and can-
didate genes identified from molecular and cellular stud-
ies) may deserve particular attention in our future en-
deavors. Once the genomic regions are confirmed,
subsequent fine-mapping studies need to be pursued to
pinpoint the QTLs to genomic regions !1 cM, for even-
tual identification of the genes and functional mutations
involved in the variation of the obesity phenotypes. The
candidate genes identified in genomic regions linked to
obesitymay be subject to association studies and/or trans-
mission-disequilibrium studies (Spielman et al. 1993; Al-
lison 1997) for confirmation of linkage and association.
Efforts from multiple approaches and from various
groups for the study of different populations should even-
tually unravel the QTLs that are important for obesity.
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Appendix A
Table A1
Basic Characteristics of the Study Subjects for BMI, Fat Mass, Lean Mass, and PFM
Stratified by Sex and Age
AGE RANGE
(YEARS)
AND SEX
MEAN (SD) [SAMPLE SIZE] FOR
BMIa
(kg/m2)
Fat Mass
(kg)
Lean Mass
(kg) PFM
20–29:
M 24.93 (3.07) [23] 16.26 (9.16) [14] 61.21 (7.14) [14] .19 (.09) [14]
F 24.63 (5.32) [40] 23.65 (11.69) [33] 41.51 (4.82) [33] .34 (.08) [33]
30–39:
M 26.94 (4.00) [69] 19.72 (9.67) [35] 60.55 (7.16) [35] .23 (.08) [35]
F 25.00 (4.86) [101] 24.7 (8.10) [61] 41.31 (5.21) [35] .35 (.07) [35]
40–49:
M 27.12 (3.47) [65] 23.15 (7.89) [29] 59.88 (6.76) [29] .26 (.05) [29]
F 26.75 (6.31) [110] 27.73 (11.79) [60] 40.89 (6.08) [60] .38 (.08) [60]
50–59:
M 28.02 (3.36) [32] 24.07 (7.57) [13] 59.11 (4.7) [13] .28 (.05) [13]
F 26.15 (5.41) [55] 28.39 (11.33) [16] 39.02 (5.69) [16] .40 (.07) [16]
60–69:
M 28.43 (4.93) [33] 20.56 (4.62) [5] 60.78 (9.73) [5] .24 (.02) [5]
F 27.2 (5.93) [58] 29.95 (9.21) [13] 36.68 (4.53) [13] .43 (.06) [13]
70:
M 27.74 (3.72) [30] 21.84 (6.90) [6] 55.26 (3.05) [6] .27 (.05) [6]
F 25.87 (3.36) [42] 23.57 (7.22) [4] 35.15 (2.59) [4] .39 (.07) [4]
a For BMI, the total sample size shown is 658. The number is greater than the 630 subjects
genotyped, because markers of 28 subjects could not be amplified (usually as a result of poor
quality or degradation of the DNA) or because our archive contained only phenotype data.
However, because the genotypes of these 28 subjects can often be unambiguously inferred from
their relatives, their phenotype data are useful in linkage analyses. Therefore, their phenotype
data are also included in the summary for the above table.
Appendix B
Table B1
Relationships Used in Analyses by SOLAR
RELATIVE PAIR
NO. OF PAIRS MEASURED FOR
BMI FM and LMa
Parent-offspring 1,380 892
Sibling 1,249 744
Grandparent-grandchild 1,098 710
Avuncular 1,993 1,148
Half sibling 23 22
Great grandparent–grandchild 356 222
Grand avuncular 445 147
Half avuncular 23 23
Great grand avuncular 3 3
Great great grandparent-grandchild 6 6
First cousin 2,589 1,500
First cousin, once removed 1,607 528
First cousin, twice removed 3 3
Half first cousin 13 13
Second cousin 1,971 755
Second cousin, once removed 12 12
Total 12,771 6,728
a FM p fat mass; LM p lean mass.
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